IBT
SGEN

International Biotechnology Trust’s Seagen Inc. Common Stock SGEN Stock Holding History

International Biotechnology Trust’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-200,200
Closed -$40.5M – 75
2023
Q1 		$40.5M Buy
200,200
+34,000
+20% +$5.45M 11.3% 1
2022
Q4 		$21.4M Hold
166,200
– – 6.6% 2
2022
Q3 		$22.7M Buy
166,200
+154,593
+1,332% +$25.2M 7.29% 2
2022
Q2 		$65.6K Sell
11,607
-64,593
-85% -$9.31M 0.68% 33
2022
Q1 		$225K Sell
76,200
-37,000
-33% -$5.01M 0.05% 68
2021
Q4 		$17.5M Buy
113,200
+3,500
+3% +$586K 3.89% 9
2021
Q3 		$18.6M Sell
109,700
-35,300
-24% -$5.49M 4.49% 6
2021
Q2 		$22.9M Buy
145,000
+12,000
+9% +$1.78M 6.04% 3
2021
Q1 		$18.5M Buy
133,000
+67,500
+103% +$10.9M 4.88% 7
2020
Q4 		$11.5M Hold
65,500
– – 3.13% 14
2020
Q3 		$12.8M Buy
65,500
+10,000
+18% +$1.67M 4.14% 9
2020
Q2 		$9.12M Sell
55,500
-1,400
-2% -$209K 3.03% 14
2020
Q1 		$6.56M Sell
56,900
-7,100
-11% -$786K 2.99% 14
2019
Q4 		$7.31M Sell
64,000
-2,400
-4% -$255K 2.63% 15
2019
Q3 		$5.67M Buy
66,400
+5,500
+9% +$403K 2.62% 16
2019
Q2 		$4.21M Hold
60,900
– – 1.56% 20
2019
Q1 		$4.46M Buy
60,900
+18,400
+43% +$1.31M 1.65% 24
2018
Q4 		$1.89M Hold
42,500
– – 1.17% 25
2018
Q3 		$2.51M Hold
42,500
– – 1.19% 27
2018
Q2 		$2.82M Hold
42,500
– – 1.08% 31
2018
Q1 		$2.22M Sell
42,500
-15,000
-26% -$817K 0.87% 28
2017
Q4 		$3.08M Hold
57,500
– – 1.08% 28
2017
Q3 		$3.13M Sell
57,500
-7,500
-12% -$384K 1.22% 25
2017
Q2 		$3.36M Hold
65,000
– – 1.28% 26
2017
Q1 		$4.09M Buy
+65,000
New +$4.06M 1.56% 19

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

International Biotechnology Trust's SGEN Position: Q2 2023 in Review

International Biotechnology Trust sold out of Seagen Inc. Common Stock (SGEN) in Q2 2023, closing a stake of 200,200 shares — an estimated $40.5M sold.

International Biotechnology Trust first reported a position in SGEN in Q1 2017 and held it in 25 quarters. The position peaked at $40.5M in Q1 2023. 594 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

  • International Biotechnology Trust reported no remaining Seagen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • International Biotechnology Trust sold 200,200 Seagen Inc. Common Stock shares in Q2 2023, an estimated $40.5M.
  • International Biotechnology Trust first reported a position in Seagen Inc. Common Stock in Q1 2017 and held it in 25 quarters.
  • International Biotechnology Trust's Seagen Inc. Common Stock position peaked at $40.5M in Q1 2023.
  • 594 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on International Biotechnology Trust's 13F filing for Q2 2023, filed 8 Aug 2023.